A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment

A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment

Our study aimed to develop an immune prognostic signature that could provide accurate guidance for the treatment of esophageal squamous cell cancer (ESCC). By implementing Single-Sample Gene Set Enrichment Analysis (ssGSEA), we established two ESCC subtypes (Immunity High and Immunity Low) in GSE536...

Full description

Bibliographic Details
Main Authors: Jianyao Gao, Ting Tang, Baohui Zhang, Guang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
esophageal squamous cell carcinoma
prognosis
signature
immunotherapy
cancer drug resistance
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.603634/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.603634/full

Similar Items